Drug Discovery with Computational Chemistry
July 19, 2011
July 20, 2011 | Nimbus Discovery is using computational chemistry to drive the drug discovery process. The company emerged from a partnership with Schrödinger, a maker of computational drug discovery software, and venture capital firm Atlas Venture. Nimbus will use Schrödinger's software, computing power, and modeling experts to develop drugs for disease-linked proteins that have historically been difficult to target. Technology Review
